Did Short Sellers In Inovio Listen To The Wrong Piper?
- Current data suggests positive results that will amplify Phase l results.
- Short sellers reacted quickly to a headline that was sensational and inaccurate.
- Inovio CEO refutes article, reiterates confident position about pending results.
- Blog piece shows a clear misunderstanding of the Trimble trial compared to Inovio trial.